BioSig Advances Collaboration On Machine Learning And Artificial Intelligence Solutions For Healthcare
Portfolio Pulse from Happy Mohamed
BioSig Technologies is advancing its collaboration with Reified Labs to develop an artificial intelligence (AI) medical device platform. The platform will be based on integrated healthcare datasets, starting with ECG and IECG data from BioSig's PURE EP™ Platform. The collaboration aims to integrate electrophysiology-focused solutions into the PURE EP™ technology for potential commercial applications.
June 27, 2023 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioSig Technologies is collaborating with Reified Labs to develop an AI medical device platform, potentially integrating electrophysiology-focused solutions into the PURE EP™ technology for commercial applications.
The collaboration between BioSig Technologies and Reified Labs aims to develop an AI medical device platform, which could lead to the integration of electrophysiology-focused solutions into the PURE EP™ technology. This has the potential to enhance the commercial applications of the technology, positively impacting BioSig's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100